Bone mechanical properties were altered in a mouse model of multiple myeloma bone disease
Source abstract
Abstract
Multiple myeloma bone disease (MMBD) is characterized by the growth of malignant plasma cells in bone marrow, leading to an imbalance in bone (re)modeling favoring excessive resorption. Loss of bone mass and altered microstructure characterize MMBD in humans and preclinical animal models, although, no study to date has examined bone composition or material properties. We hypothesized that MMBD alters bone composition, mineral crystal properties and mechanical properties in the MOPC315.BM.Luc model after intra-tibial injection of myeloma cells and three weeks of daily in vivo tibial loading. Decreased cortical bone elastic modulus and hardness measured by nanoindentation of tibiae were observed in MM-injected mice compared to PBS-injected mice, whereas cortical bone composition, mineral crystal properties measured by Fourier-transform infrared imaging or small angle X-ray scattering, respectively remained unchanged. However, MM-injected mice had thinner cancellous bone mineral particles compared to PBS-injected mice. Mechanical loading did not lead to altered cortical bone composition, mineral structure, or mechanical properties in the context of MM. Unexpectedly, we observed the intra-tibial injection itself altered the material composition of bone, manifested by increased matrix mineralization and crystal size of the hydroxyapatite crystals in the bone matrix. In conclusion, our data suggest that mechanical stimuli can be used as an adjuvant bone anabolic therapy in patients with MMBD to rebuild bone with unaltered composition and mineral structure to reduce subsequent fracture risk.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone health and treatments · Orthopaedic implants and arthroplasty · Bone Metabolism and Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (63)
Show source-provided references
1. Multiple myeloma10.1016/S0140-6736(14)60493-1 ↗
2. Myeloma bone disease: Pathophysiology and management10.1016/j.jbo.2013.04.001 ↗
3. Biology and treatment of myeloma related bone disease10.1016/j.metabol.2017.11.012 ↗
4. Multiple Myeloma Bone Disease
5. Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival10.1359/jbmr.2003.18.3.482 ↗
6. Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth10.1038/leu.2017.152 ↗
7. A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease10.1371/journal.pone.0051892 ↗
8. Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma10.1182/blood-2017-03-773341 ↗
9. Low intensity vibration mitigates tumor progression and protects bone quantity and quality in a murine model of myeloma10.1016/j.bone.2016.05.014 ↗
10. Mouse models of multiple myeloma: technologic platforms and perspectives10.18632/oncotarget.24614 ↗
11. Mechanical loading prevents bone destruction and exerts anti-tumor effects in the MOPC315.BM.Luc model of myeloma bone disease10.1016/j.actbio.2020.10.041 ↗
12. An Early Myeloma Bone Disease Model in Skeletally Mature Mice as a Platform for Biomaterial Characterization of the Extracellular Matrix10.1155/2020/3985315 ↗
13. Mechanical behavior of metastatic vertebrae are influenced by tissue architecture, mineral content, and organic feature alterations10.1002/jor.24105 ↗
14. The impact of metastasis on the mineral phase of vertebral bone tissue10.1016/j.jmbbm.2016.12.017 ↗
15. Collagen fibril organization within rat vertebral bone modified with metastatic involvement10.1016/j.jsb.2017.06.008 ↗
16. Osteolytic and mixed cancer metastasis modulates collagen and mineral parameters within rat vertebral bone matrix10.1002/jor.23248 ↗
17. Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis10.1073/pnas.1708161114 ↗
18. Prostate cancer metastases alter bone mineral and matrix composition independent of effects on bone architecture in mice--a quantitative study using microCT and Raman spectroscopy10.1016/j.bone.2013.07.006 ↗
19. Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study10.1182/bloodadvances.2020002378 ↗
20. Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease10.1007/s11914-017-0403-y ↗
21. Bone anabolic agents for the treatment of multiple myeloma10.1007/s12307-011-0090-7 ↗
22. Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma10.1073/pnas.0610299104 ↗
23. Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone10.1371/journal.pone.0015233 ↗
24. Prevention of Bone Destruction by Mechanical Loading Is Not Enhanced by the Bruton’s Tyrosine Kinase Inhibitor CC-292 in Myeloma Bone Disease10.3390/ijms22083840 ↗
25. Osteoblast suppression in multiple myeloma bone disease10.1016/j.jbo.2018.09.001 ↗
26. Myeloma cells suppress osteoblasts through sclerostin secretion10.1038/bcj.2011.22 ↗
27. Effect of in vivo loading on bone composition varies with animal age10.1016/j.exger.2015.01.048 ↗
28. Osteocyte remodeling of the perilacunar and pericanalicular matrix10.4248/ijos.09019 ↗
29. Diminished response to in vivo mechanical loading in trabecular and not cortical bone in adulthood of female C57Bl/6 mice coincides with a reduction in deformation to load10.1016/j.bone.2013.04.023 ↗
30. Infrared assessment of bone quality: a review10.1007/s11999-010-1751-4 ↗
31. Raman and Fourier transform infrared imaging for characterization of bone material properties10.1016/j.bone.2020.115490 ↗
32. A customizable software for fast reduction and analysis of large X-ray scattering data sets: applications of the new DPDAK package to small-angle X-ray scattering and grazing-incidence small-angle X-ray scattering10.1107/S1600576714019773 ↗
33. PyFAI: a Python library for high performance azimuthal integration on GPU10.1017/S0885715613000924 ↗
34. Structure and mechanical quality of the collagen–mineral nano-composite in bone10.1039/B402005G ↗
35. Statistical model of the habit and arrangement of mineral crystals in the collagen of bone10.1007/BF02186835 ↗
36. Die Röntgenkleinwinkelstreuung von dichtgepackten kolloiden Systemen10.1007/BF01512792 ↗
37. Scanning small angle X-ray scattering analysis of human bone sections10.1007/PL00005824 ↗
38. An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experiments10.1557/JMR.1992.1564 ↗
39. Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model10.1038/bcj.2014.37 ↗
40. Reduced concentrations of collagen cross-links are associated with reduced strength of bone10.1016/8756-3282(95)00328-B ↗
41. Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links10.1359/jbmr.2002.17.9.1621 ↗
42. Bone volume fraction explains the variation in strength and stiffness of cancellous bone affected by metastatic cancer and osteoporosis10.1007/s00223-008-9174-x ↗
43. Cooperative deformation of mineral and collagen in bone at the nanoscale10.1073/pnas.0604237103 ↗
44. Fragility of Bone Material Controlled by Internal Interfaces10.1007/s00223-015-9978-4 ↗
45. Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales10.1073/pnas.1107966108 ↗
46. Combination of nanoindentation and quantitative backscattered electron imaging revealed altered bone material properties associated with femoral neck fragility10.1007/s00223-009-9289-8 ↗
47. Fourier transform infrared spectroscopic imaging parameters describing acid phosphate substitution in biologic hydroxyapatite10.1007/s00223-013-9695-9 ↗
48. Variation in within-bone stiffness measured by nanoindentation in mice bred for high levels of voluntary wheel running10.1111/j.1469-7580.2009.01175.x ↗
49. Fractures and survival in multiple myeloma: results from a population-based study10.3324/haematol.2019.230011 ↗
50. Adipose, Bone, and Myeloma: Contributions from the Microenvironment10.1007/s00223-016-0162-2 ↗
51. The regional acceleratory phenomenon: a review
52. Fourier Transform Infrared Spectroscopic Imaging of Fracture Healing in the Normal Mouse
53. Correlations between nanostructure and micromechanical properties of healing bone10.1016/j.jmbbm.2017.08.022 ↗
54. Spatial and temporal variations of mechanical properties and mineral content of the external callus during bone healing10.1016/j.bone.2009.04.249 ↗
55. Exercise alters mineral and matrix composition in the absence of adding new bone10.1159/000151452 ↗
56. Bone structure: from angstroms to microns10.1096/fasebj.6.3.1740237 ↗
57. Adaptive crystal formation in normal and pathological calcifications in synthetic calcium phosphate and related biomaterials10.1016/S0074-7696(08)62360-8 ↗
58. Age-specific profiles of tissue-level composition and mechanical properties in murine cortical bone10.1016/j.bone.2011.12.026 ↗
59. Composition and microarchitecture of human trabecular bone change with age and differ between anatomical locations10.1016/j.bone.2013.01.045 ↗
60. The effectiveness of exercise programmes in patients with multiple myeloma: A literature review10.1016/j.critrevonc.2015.11.005 ↗
61. A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors10.1186/1471-2407-13-31 ↗
62. Exercise interventions on health-related quality of life for people with cancer during active treatment10.1111/coa.12015 ↗
63. Fatigue and quality of life outcomes of exercise during cancer treatment10.1046/j.1523-5394.2001.009003119.x ↗